DiscoverPharmaTalkRadioEnhanced Strategic FDA Collaboration: Working with CDER and CBER
Enhanced Strategic FDA Collaboration: Working with CDER and CBER

Enhanced Strategic FDA Collaboration: Working with CDER and CBER

Update: 2025-06-26
Share

Description

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can best support their regulatory teams and engage with the FDA and other regulators. Specifically, the panelists address:
  • Engaging with the FDA on a peer-to-peer level
  • Effectively negotiating about innovative approaches that may be outside of guidelines
  • How to react and respond to feedback and questions from the FDA

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Enhanced Strategic FDA Collaboration: Working with CDER and CBER

Enhanced Strategic FDA Collaboration: Working with CDER and CBER

Conference Forum